Recursion Pharmaceuticals is a biotechnology company that uses artificial intelligence and machine learning to discover new drugs. The company's proprietary platform combines high-throughput biology, chemistry, and image-based data with machine learning algorithms to identify new treatments for diseases. Recursion Pharmaceuticals is focused on developing treatments for rare genetic diseases, including lysosomal storage disorders, neurodegenerative diseases, and oncology. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.